ATE553760T1 - Verwendung von alverin zur behandlung von hauterkrankungen - Google Patents

Verwendung von alverin zur behandlung von hauterkrankungen

Info

Publication number
ATE553760T1
ATE553760T1 AT09171044T AT09171044T ATE553760T1 AT E553760 T1 ATE553760 T1 AT E553760T1 AT 09171044 T AT09171044 T AT 09171044T AT 09171044 T AT09171044 T AT 09171044T AT E553760 T1 ATE553760 T1 AT E553760T1
Authority
AT
Austria
Prior art keywords
alverine
skin diseases
antibacterial
treat skin
salts
Prior art date
Application number
AT09171044T
Other languages
English (en)
Inventor
Francois Fauran
Original Assignee
Francois Fauran
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Francois Fauran filed Critical Francois Fauran
Application granted granted Critical
Publication of ATE553760T1 publication Critical patent/ATE553760T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Surface Acoustic Wave Elements And Circuit Networks Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
AT09171044T 2008-09-23 2009-09-23 Verwendung von alverin zur behandlung von hauterkrankungen ATE553760T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0856382A FR2936149B1 (fr) 2008-09-23 2008-09-23 Utilisation de l'alverine dans le traitement des affections cutanees

Publications (1)

Publication Number Publication Date
ATE553760T1 true ATE553760T1 (de) 2012-05-15

Family

ID=40513974

Family Applications (1)

Application Number Title Priority Date Filing Date
AT09171044T ATE553760T1 (de) 2008-09-23 2009-09-23 Verwendung von alverin zur behandlung von hauterkrankungen

Country Status (7)

Country Link
EP (1) EP2165704B1 (de)
AT (1) ATE553760T1 (de)
DK (1) DK2165704T3 (de)
ES (1) ES2386558T3 (de)
FR (1) FR2936149B1 (de)
PL (1) PL2165704T3 (de)
PT (1) PT2165704E (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2444068T4 (en) † 2010-10-21 2018-03-05 Galderma Sa Brimonide sub-composition
CN102626415B (zh) * 2012-03-21 2014-08-06 山东省千佛山医院 四环素类药物联合应用氟康唑在制备抗真菌产品中的应用及其产品
EP2885421A1 (de) * 2012-07-13 2015-06-24 L'Oréal SA Verfahren zur in-vitro-diagnose eines häutchenförmig zustandes bei einer person und zugehörige anwendungen
KR102057173B1 (ko) 2018-04-05 2019-12-18 삼척시 알베린 화합물을 유효성분으로 포함하는 항산화 조성물
KR102261340B1 (ko) * 2018-12-28 2021-06-07 삼척시 민물김 추출물을 유효성분으로 포함하는 염증성 피부 질환 예방 또는 치료용 조성물
WO2022018297A1 (en) * 2020-07-24 2022-01-27 Association Francaise Contre Les Myopathies Use of alverine or its derivatives for the treatment of mitochondrial diseases or dysfunction associated with mitochondrial complex i deficiencies
FR3154314A1 (fr) * 2023-10-20 2025-04-25 Laboratoires Mayoly Spindler Composition pharmaceutique comprenant de la siméticone et de l’alvérine citrate, composition pharmaceutique contenant de la siméticone, composition pharmaceutique,comprenant de l’alvérine citrate, et leurs procédés de fabrication.

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2798590B1 (fr) * 1999-09-21 2001-11-30 Oreal Utilisation de l'alverine pour diminuer les rides
FR2823114B1 (fr) * 2001-04-09 2003-05-23 Oreal Utilisation de l'alverine ou de l'un de ses sels
FR2823109B1 (fr) 2001-04-09 2003-05-23 Oreal Utilisation de l'alverine ou de l'un de ses sels pour stimuler ou induire la pousse des cheveux et/ou stopper leur chute
FR2826267B1 (fr) * 2001-06-26 2005-02-25 Oreal Composition cosmetique ou dermatologique comprenant une association entre un compose inhibiteur de l'elastase de la famille des n-acylaminoamides et au moins un agent myorelaxant
WO2005002560A1 (fr) 2003-06-13 2005-01-13 Cerep Utilisation de l’alverine, seul ou en combinaison avec un antidepresseur tricyclique ou un antidepresseur inhibiteur specifique de la recapture de la serotonine pour le traitement de la depression
FR2900337A1 (fr) 2006-04-28 2007-11-02 Cerep Sa Utilisation de l'alverine pour le traitement des dysfonctions sexuelles
WO2008009860A2 (fr) * 2006-07-21 2008-01-24 L'oreal Utilisation de composés antagonistes des canaux calcium pour dépigmenter la peau

Also Published As

Publication number Publication date
EP2165704B1 (de) 2012-04-18
DK2165704T3 (da) 2012-08-06
EP2165704A1 (de) 2010-03-24
FR2936149A1 (fr) 2010-03-26
PL2165704T3 (pl) 2012-10-31
PT2165704E (pt) 2012-07-05
ES2386558T3 (es) 2012-08-22
FR2936149B1 (fr) 2013-01-04

Similar Documents

Publication Publication Date Title
ATE553760T1 (de) Verwendung von alverin zur behandlung von hauterkrankungen
BRPI1009652A2 (pt) tecidos anticrobianos compreendendo peróxido
PH12019501469A1 (en) Compositions and methods for treating biofilms
EA201391566A1 (ru) Комбинации активных соединений, содержащие производное соединение (тио)карбоксамида и фунгицидное соединение
EA201290078A1 (ru) Гетероциклические соединения для ингибирования pask
ATE525084T1 (de) Verwendung von mindestens einem botulinum- neurotoxin zur behandlung von schmerzen infolge therapeutischer behandlungen für das aids-virus
MX355153B (es) Combinaciones de compuestos activos que comprenden derivados de carboxamida y un agente de control biologico.
MY160004A (en) Heterocyclically substituted aryl compounds as hif inhibitors
DE50311898D1 (de) Fredericamycin-derivate als arzneimittel zur tumorbehandlung
NO20083005L (no) Anvendelse av benzofuserte heterocykliske sulfamidderivater for behandling av smerte
EA200971053A1 (ru) Способы лечения кожных язв
MX2021005136A (es) Composiciones y métodos para el tratamiento de biopelículas sin inducir resistencia a los antimicrobianos.
ATE495745T1 (de) 1-ä2-(2,4-dimethylphenylsulfanyl)phenylüpiperaz n als verbindung mit kombinierter serotonin- aufnahme, 5-ht3- und 5-ht1a-aktivität zur behandlung von schmerzen oder restsymptomen bei depressionen im zusammenhang mt schlaf und kognition
EA201891507A1 (ru) Кислая альфа-глюкозидаза усиленного действия для лечения болезни помпе
NO20083036L (no) Anvendelse av benzofuserte heterocykliske sulfamidderivater for behandling av depresjon
RU2014150505A (ru) Способ идентификации лигандов рецептора ahr, которые обладают терапевтической себосупрессивной активностью, и указанные лиганды
UA95103C2 (ru) Замещенные арилсульфонамиды в качестве противовирусных средств
EP4297765A4 (de) Zusammensetzung zur behandlung von topischen dermatologischen bakteriellen hauterkrankungen
DE502008003215D1 (de) Mittel und verfahren zur gerbung von häuten und fellen
ATE429916T1 (de) Verwendung von sulfonamid-derivaten bei der behandlung von adipositas oder zur verringerung der nahrungsaufnahme
BRPI0720236A2 (pt) Composto ou sal farmaceuticamente aceitável do mesmo, processo para preparar o mesmo, uso de um composto ou um sal farmaceuticamente aceitável do mesmo, método para tratar uma infecção bacteriana em um animal de sangue quente tal como o ser humano, e, composição farmacêutica
EA201390487A1 (ru) Антимикробный белок
NZ594450A (en) Antimicrobial composition
ATE487480T1 (de) Perhexilin zur behandlung von chronischer herzinsuffizienz
ATE556134T1 (de) Mesenchymstammzellen und verwendungendafür